Related Experiment Videos
Progress in myocardial regeneration and cell transplantation
1Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Medicine, Tokyo, Japan. kfukuda@sc.itc.keio.ac.jp
Summary
Researchers are regenerating heart cells from stem cells for heart failure treatment. Tissue engineering advances allow for donor-free cardiomyocyte cell sheets, reaching preclinical stages for heart repair therapies.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart failure remains a leading cause of mortality worldwide.
- Current treatments for heart failure have limitations.
- Regenerative approaches offer potential for cardiac repair.
Purpose of the Study:
- To explore the potential of stem cell-derived cardiomyocytes for heart failure treatment.
- To review advances in tissue engineering for cardiac cell therapies.
- To assess the feasibility of using mobilized stem cells for cardiac regeneration.
Main Methods:
- Induction of cardiomyocyte differentiation from embryonic stem cells and bone marrow mesenchymal stem cells.
- Development of techniques for purification and transplantation of regenerated cardiomyocytes.
- Application of tissue engineering for creating cardiomyocyte cell sheets.
- Investigation of cytokine-induced stem cell mobilization for heart failure.
Main Results:
- Regenerated cardiomyocytes can survive long-term in recipient hearts after transplantation.
- Cardiomyocyte cell sheets produced via tissue engineering are nearing preclinical application for heart failure.
- Stem cell mobilization using cytokines is an emerging strategy for heart failure treatment.
Conclusions:
- Stem cell-based therapies, including regenerated cardiomyocytes and cell sheets, show significant promise for treating heart failure.
- Tissue engineering advancements are crucial for developing donor-free cardiac cell transplantation.
- Further research into stem cell mobilization and cardiomyocyte regeneration is warranted for clinical translation.